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Influence of Body Weight on Surgical
Treatment for Neurogenic Thoracic Outlet
Syndrome
J. Westley Ohman, Ahmmad A. Abuirqeba, Senthil N. Jayarajan, Joshua Balderman,
and Robert W. Thompson, St. Louis, Missouri

Background: Body weight affects outcomes of surgical treatment for various conditions, but its
effects on the treatment of neurogenic thoracic outlet syndrome (NTOS) are unknown. The purpose of this study was to evaluate the influence of body weight on technical and functional outcomes of surgical treatment for NTOS.
Methods: A retrospective review of prospectively collected data was conducted for 265
patients who underwent supraclavicular decompression for NTOS between January 1,
2014 and March 31, 2016. Patients were grouped according to 6 standard body mass index
(BMI) categories. The influence of BMI on measures of surgical outcome was analyzed using
Pearson correlation statistics, analysis of variance (ANOVA), and multivariate logistic
regression.
Results: Mean patient age was 33.3 ± 0.7 years (range, 12e70), and 208 (78%) patients were
women. Mean BMI was 27.2 ± 0.4 (range 16.8e49.9), with 7 underweight (3%), 95 normal
(36%), 84 overweight (32%), 47 obese-I (18%), 15 obese-II (6%), and 17 obese-III (6%). There
was a slight but significant association between BMI and age (Pearson P < 0.0001, r ¼ 0.264;
ANOVA P ¼ 0.0002), but no correlations between BMI and other preoperative variables. There
were no differences between BMI groups for intraoperative, immediate postoperative, or
3-month outcomes. Multivariate logistic regression demonstrated that BMI had no significant
effect on functional outcome as measured by the extent of improvement in Disability of the
Arm, Shoulder, and Hand score at 3 months (P ¼ 0.429).
Conclusions: There was no substantive influence of BMI on preoperative characteristics or
intraoperative, postoperative, or 3-month outcomes for patients with NTOS, and no indication
of an ‘‘obesity paradox’’ for this condition. Supraclavicular decompression for NTOS achieves
similar outcomes across the BMI spectrum.

INTRODUCTION
Conflicts of interest: The authors declare that they have no conflicts of
interest to disclose.
Center for Thoracic Outlet Syndrome, Section of Vascular Surgery,
Department of Surgery, Washington University School of Medicine,
St. Louis, MO.
Correspondence to: Robert W. Thompson, MD, Center for Thoracic
Outlet Syndrome, Section of Vascular Surgery, Washington University
School of Medicine, 5101 Queeny Tower, One Barnes-Jewish Hospital
Plaza, Campus Box 8109, St. Louis, MO 63110, USA; E-mail:
thompson@wudosis.wustl.edu
Ann Vasc Surg 2018; 49: 80–90
https://doi.org/10.1016/j.avsg.2017.10.031
Ó 2018 The Author(s). Published by Elsevier Inc. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Manuscript received: May 27, 2017; manuscript accepted: October 15,
2017; published online: 5 February 2018

80

The worldwide prevalence of obesity has increased
over the past several decades. In the United States,
current data indicate that 69% of adults are overweight, with 35% meeting criteria for obesity.1
These findings have broad implications for medical
care given strong associations between obesity and
diabetes, hypertension, hyperlipidemia, and other
conditions. Increased body weight may also affect
the incidence and outcomes of treatment for surgical diseases, by increasing the technical difficulty
of abdominal and pelvic operations, elevating the
risk of postoperative complications (such as wound
infection and dehiscence, pneumonia, obstructive
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sleep apnea, and deep vein thrombosis), and prolonging hospital stay, recovery from operation,
and functional rehabilitation.2e12
The effect of body weight on the conduct and outcomes of surgical treatment has been widely studied, with increased cardiovascular risk observed at
higher body mass index (BMI) categories and an
increased incidence of cardiovascular complications
regardless of other risk factors.2,13,14 Prospective
cohort studies in general surgery have also shown
surgical site infections, and postoperative mortality
are positively associated with obesity.3,7e10,12 However, when stratified by body weight category, the
lowest risk for postoperative mortality has been
among those overweight and in obesity class I,
giving rise to the concept of an ‘‘obesity paradox’’
in which mild elevations in BMI seem to be
protective.5,11,12
Neurogenic thoracic outlet syndrome (NTOS) is
an uncommon condition caused by dynamic
brachial plexus nerve compression within the
supraclavicular scalene triangle and/or the subcoracoid (pectoralis minor) space, resulting in positional
upper extremity pain, numbness, and paresthesia.15
NTOS can be particularly disabling because this condition often affects young, active, individuals in the
prime working years. The outcomes of surgical
treatment for NTOS have been examined with
increasing rigor over the past decade, in part to
help better identify factors that influence treatment
results, but to date, there have been no studies
addressing the potential effects of body weight on
outcomes of surgical treatment for NTOS.16e26 The
purpose of this study was to evaluate the effect of
body weight on intraoperative, technical, postoperative, and functional outcomes following supraclavicular decompression for NTOS at a high-volume
academic medical center.

METHODS
Study Population
All subjects in this study gave informed consent for
the publication of their medical data, through a
protocol approved by the Human Research Protection Office at Washington University, St. Louis,
Missouri. The study population consisted of all patients undergoing surgical treatment for NTOS at
the Washington University Center for Thoracic
Outlet Syndrome at Barnes-Jewish Hospital
(St. Louis, MO) from January 1, 2014 to March
31, 2016. Each patient met predefined clinical diagnostic criteria for NTOS.24,27e29 Indications for surgical treatment included a sound clinical diagnosis,
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significantly disabling symptoms, and absence of
satisfactory improvement following conservative
management with NTOS-specific physical therapy.15,20e23 All patients underwent supraclavicular
scalenectomy, first rib resection, and brachial plexus
neurolysis, with concomitant pectoralis minor
tenotomy through an additional deltopectoral
groove incision, when indicated by physical examination findings, as previously described.15,20e23 Patients undergoing isolated pectoralis minor
tenotomy as surgical treatment for NTOS were
excluded from analysis. Data were collected from office notes, hospital records, imaging studies, and records from treating physicians and therapists,
including Disability of the Arm, Shoulder, and
Hand (DASH) scores to assess functional disability
and entered into a prospectively maintained
database.
Body Weight Groups
Patients were grouped into 6 categories according to
BMI at the time of surgical treatment: (1) underweight, BMI < 18.5; (2) normal, BMI 18.6e25.0;
(3) overweight, BMI 25.1e30.0; (4) obese-I, BMI
30.1e35.0; (5) obese-II, BMI 35.1e40.0; or
(6) obese-III, BMI > 40.0.
Statistical Analysis
Descriptive data are presented as the incidence and
proportions for categorical data and as the
mean ± SEM for continuous measures. For analysis
of BMI as a continuous variable, Pearson correlation
tests were performed with calculation of P, r, and R2
values. For analysis of BMI as a categorical variable,
multiple-group comparisons were conducted with
analysis of variance (ANOVA) and Tukey’s multiple
comparisons test, where appropriate. Multivariate logistic regression was used to analyze associations between preoperative patient characteristics and
functional outcome. All statistical tests were performed using either Prism, version 6.0 h (GraphPad
Software, Inc., San Diego, CA) or SAS, version 9.3
(SAS Institute, Inc., Cary, NC), with P values < 0.05
considered significant.

RESULTS
Patient Characteristics
Two-hundred sixty-five patients underwent surgical
treatment for NTOS between January 1, 2014 and
March 31, 2016. The mean age of the study population was 33.3 ± 0.7 years (range, 12 to 70 years).
There were 208 (77%) women, 150 (57%) with
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Table I. Presenting characteristics and operative outcomes of patients with NTOS by body mass index
group
Group (BMI)

Underweight
(<18.5)

Normal
(18.6e25)

Overweight
(25.1e30)

Obese-I (30.1e35)

Obese-II (35.1e40)

Obese-III (>40)

No. of patients (%)
Age (years)*
Female (%)z
Right side (%)z
Rib anomalyz
Height (in)y
Weight (kg)y
BMIy
Preop DASHy
OR time (min)y
EBL (mL)y
Fluid (L)y
ASM (g)y
MSM (g)y
LOS (days)y
Drain (L)y
Drain (days)y
Lymph Leakz
Readmitz
Postop DASHy
D DASHy
D DASH %y
Improved %z

7 (3%)
24 ± 4
7 (100%)
5 (71%)
1 (14%)
65 ± 0.5
48 ± 1
17 ± 0.2
62 ± 9.4
181 ± 6
36 ± 9
2.6 ± 0.4
6.7 ± 0.4
4.9 ± 0.6
4.7 ± 0.9
0.7 ± 0.1
5.9 ± 0.5
0 (0%)
0 (0%)
41 ± 13.5
12 ± 7.9
44 ± 16.3
86%

95 (36%)
30 ± 1
77 (81%)
60 (63%)
16 (17%)
67 ± 0.4
64 ± 1
22 ± 0.2
59 ± 2.0
181 ± 2
56 ± 9
3.0 ± 0.1
7.5 ± 0.2
5.7 ± 0.2
4.3 ± 0.1
1.1 ± 0.9
5.8 ± 0.1
1 (1%)
3 (3%)
41 ± 2.7
23 ± 5.9
25 ± 5.5
70%

84 (32%)
33 ± 1
63 (75%)
46 (55%)
4 (5%)
67 ± 0.5
78 ± 1
27 ± 0.2
55 ± 2.1
182 ± 3
60 ± 8
3.0 ± 0.1
7.9 ± 0.2
6.1 ± 0.3
4.6 ± 0.2
1.2 ± 0.1
5.9 ± 0.2
2 (2%)
4 (5%)
37 ± 2.6
20 ± 2.8
30 ± 5.0
75%

47 (18%)
39 ± 2
36 (77%)
22 (47%)
4 (8%)
66 ± 0.5
89 ± 1
31 ± 0.2
61 ± 2.7
186 ± 4
54 ± 10
3.2 ± 0.1
7.8 ± 0.3
5.5 ± 0.3
4.6 ± 0.4
1.1 ± 0.2
5.9 ± 0.4
2 (4%)
2 (4%)
47 ± 3.8
14 ± 3.1
24 ± 6.2
81%

15 (6%)
38 ± 3
12 (80%)
8 (53%)
2 (13%)
66 ± 1.0
104 ± 3
36 ± 0.3
69 ± 3.9
189 ± 7
67 ± 37
3.3 ± 0.3
7.4 ± 0.5
7.7 ± 1.1
4.4 ± 0.4
0.8 ± 0.2
5.7 ± 0.5
0 (0%)
0 (0%)
46 ± 5.0
23 ± 5.9
31 ± 7.1
86%

17 (6%)
37 ± 2
13 (76%)
9 (53%)
1 (6%)
66 ± 1.3
120 ± 5
42 ± 0.7
64 ± 5.3
197 ± 11
60 ± 16
3.0 ± 0.2
7.8 ± 0.5
5.5 ± 0.4
4.2 ± 0.3
0.6 ± 0.9
5.5 ± 0.3
1 (6%)
2 (12%)
54 ± 6.1
12 ± 7.9
5 ± 15.3
60%

Data shown represent the number and percentage of patients or the mean ± SEM for each BMI group.
ASM, anterior scalene muscle specimen weight; D (delta), numerical decrease in DASH score from preoperative to 3-month
postoperative follow-up; Drain, output from closed-suction drain after operative procedure, expressed for total volume (liters) and
time until drain removal (days); Improved, percentage of patients exhibiting a decrease in DASH score at 30-day follow-up; Fluid,
intraoperative fluid administered; LOS, length of hospital stay after operative procedure; Lymph leak, number and percentage of
patients requiring early reoperation to control a persistent lymph leak; MSM, middle scalene muscle specimen weight; Postop,
postoperative follow-up 3 months after surgical treatment; OR time, duration of operative procedure; Readmit, hospital
readmission within 30 days of discharge.
*P < 0.05, ANOVA for differences between BMI groups.
y
P > 0.05, ANOVA for differences between BMI groups.
z
P > 0.05, Chi-square for differences between BMI groups.

right-sided symptoms and 28 (10%) with a bony abnormality (complete cervical rib, n ¼ 9; partial cervical rib, n ¼ 14; first rib hypoplasia, n ¼ 1; first rib
fracture, n ¼ 3; clavicle fracture, n ¼ 1) (Table I).
Mean BMI was 27.2 ± 0.4 (range 16.8e49.9), with
7 underweight (3%), 95 normal (36%), 84 overweight (32%), 47 obese-I (18%), 15 obese-II (6%),
and 17 obese-III (6%) (Table I and Fig. 1A, B). There
was a slight but significant association between BMI
and age (Pearson P < 0.0001, r ¼ 0.264; ANOVA
P ¼ 0.0002), but no correlations were observed between BMI and gender, side affected, or the presence
of a bony abnormality. (Table I and Fig. 1C, D).
Clinical Presentation
Approximately half of the patients had a history of a
co-existing medical condition other than NTOS, the

most frequent being anxiety disorder or depression
(n ¼ 59, 22%) and degenerative lumbar spine disease (n ¼ 41, 15%). Cardiac and pulmonary diseases
were infrequent, and diabetes was present in only 6
(2%). There was a history of previous injury in 168
patients (63%), with a relatively even distribution
between recreational, accidental, and occupational
injuries, as well as a smaller number with unclassified repetitive strain injury (Fig. 2A, B). Over half
of the patients had symptoms for 2 or more years
before referral, consistent with our previous experience (Fig. 2C, D).20,24,29 Forty-eight patients (18%)
had undergone a previous operation for the presenting symptoms without improvement, including peripheral nerve decompression, cervical spine
operations, or shoulder procedures, with 11 (4%)
having had combined or multiple previous operations (Fig. 2E, F). While 64% of patients were taking
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Fig. 1. Body mass index in patients undergoing surgical
treatment for neurogenic thoracic outlet syndrome. (A)
Histogram illustrating the distribution of BMI in 265 patients. (B) Bar graph demonstrating the mean (±SEM)
BMI for patients in each of the 6 BMI groups, with a significant difference between groups (ANOVA). The number of patients in each group is indicated in parentheses.

(C) Scatter plot illustrating correlation analysis between
BMI and patient age. (D) Bar graph showing the mean
(±SEM) age for each BMI group, with a significant difference between groups (ANOVA). UW, underweight;
N, normal; OW, overweight; Ob-I, obese-I; Ob-II,
obese-II; Ob-III, obese-III.

no pain medications or only nonsteroidal antiinflammatory drugs to manage symptoms of NTOS
before surgical treatment, over one-quarter were
taking opiates (10% strong opiates and 18% weak
opiates) (Fig. 2G, H). Three-quarters of the patients
were working (44% full time and 8% part time) or
students (23%) at the time of surgery, with the
remainder either unemployed (9%) or disabled
(16%) (Fig. 3A, B). The mean preoperative DASH
score was 59.1 ± 1.2, reflecting a substantial level
of functional disability (Fig. 3C, D). Although there
were significant associations between previous
injury and BMI, and between work status and
BMI, no correlations were observed between BMI
and co-existing medical conditions, incidence or
type of injury, duration of symptoms, pain medication use, previous operations, or preoperative
DASH scores (Figs. 2 and 3).

As shown in Table I, the overall mean duration of
operation (incision to wound closure) was
184 ± 2 minutes (range, 72e306 minutes). The
mean estimated blood loss (EBL) was 57 ± 5 mL
(range, 0e700 mL), and the amount of fluid administered was 3.0 ± 0.1 liters (range, 0.5e6.5 liters),
with no patients requiring blood transfusion. The
specimen weights of the resected anterior and middle scalene muscles were 7.7 ± 0.1 and
5.8 ± 0.2 grams, respectively, with a total scalene
muscle weight of 13.5 ± 0.2 grams. Mean hospital
length of stay was 4.5 ± 0.1 days (range,
2.7e21.9 days). Mean total postoperative drain volume was 1053 ± 72 mL, and drain duration was
5.8 ± 0.1 days. Six patients (2%) underwent early
reoperation for control of a persistent lymph leak
that had not responded to conservative measures
(clear liquid diet, parenteral nutrition, and octreotide). There were 11 (4%) readmissions within
30 days of operation, all for unsatisfactory outpatient control of postoperative pain. There was a significant correlation between BMI and duration of
operation, but no significant differences between
BMI groups for duration of operation, EBL, amount

Surgical Treatment
All patients underwent supraclavicular thoracic
outlet decompression, with 243 (92%) having
concomitant ipsilateral pectoralis minor tenotomy.
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Fig. 2. Presenting characteristics of patients with NTOS
in relation to BMI. (A and B) Frequency of previous
injury in patients with NTOS (A) and relationship between BMI and previous injury (B), with a significant
difference between groups (ANOVA). (C and D) Frequency of different duration of symptoms in patients
with NTOS (C) and relationship between BMI and duration of symptoms (D), with no significant difference between groups (ANOVA). (E and F) Frequency of
previous operations in patients with NTOS (E) and
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relationship between BMI and previous operations (F),
with no significant difference between groups (ANOVA).
(G and H) Frequency of preoperative pain medication
use in patients with NTOS (G) and relationship between
BMI and pain medication use (H), with no significant difference between groups (ANOVA). NSAIDs, nonsteroidal
anti-inflammatory
drugs;
Recr,
recreational;
Accid, accidental; Occup, occupational; Repet, repetitive
strain; CTS, carpal tunnel syndrome.
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Fig. 3. Preoperative functional status of patients with
NTOS in relation to BMI. (A and B) Frequency of work
status in patients with NTOS (A) and relationship between BMI and work status (B), with a significant difference between groups (ANOVA). (C) Scatter plot

illustrating correlation analysis between BMI and preoperative DASH score. (D) Bar graph showing the mean
(±SEM) preoperative DASH score for each BMI group,
with no significant difference between groups (ANOVA).
Unemp, unemployed.

of fluid administered, scalene muscle weight, hospital length of stay, total drain volume, drain duration,
incidence of lymph leaks requiring reoperation, or
incidence of readmissions (Table I and Fig. 4).

preoperative patient characteristics and postoperative functional outcome, as measured by the percent
improvement in DASH score at 3-month follow-up.
As shown in Table II, none of the BMI groups
exhibited a significant association with functional
improvement. Of the variables assessed, only an unemployment work status before surgery was significantly (negatively) associated with functional
outcome (odds ratio 0.236, 95% confidence interval
0.086e0.610, P ¼ 0.004).

Functional Outcomes
DASH scores were obtained at 3 months after surgery as an indicator of early functional response to
surgical treatment, with 245 patients (92%)
providing satisfactory follow-up data (Table I). The
mean follow-up DASH score was 41.6 ± 1.6, which
compared favorably with the mean preoperative
DASH score of 59.1 ± 1.2 (P < 0.0001, Manne
Whitney test). The mean numerical change in
DASH score was 17.6 ± 1.6, and the mean percentage change in DASH score was 26.3 ± 3.0%, with
an improvement in DASH score exhibited by 196
(74%) of patients. There were no correlations with
BMI or differences between BMI groups for changes
in DASH score, the percentage changes in DASH
score, or the proportion of patients with measureable functional improvement (Table I and Fig. 5).
Multivariate logistic regression was used to
further analyze associations between various

DISCUSSION
In this study, we examined the potential effects of
body weight on various aspects of surgical treatment
for NTOS. The average BMI in the study cohort
(27.2 kg/m2) was in the overweight range, but there
was a wide and even distribution of body weights
indicating a sufficiently representative sample of patients across the entire body weight spectrum. We
also evaluated a relatively large number of patients
undergoing surgical treatment for NTOS, thereby
providing an ample basis for analysis. Because all
patients who met the predefined diagnostic criteria

86 Ohman et al.

Fig. 4. Operative outcomes of patients with NTOS in
relation to BMI. (A and B) OR time. Scatter plot illustrating correlation analysis between BMI and operating
room time (A), showing a significant association, and
bar graph showing the mean (±SEM) operating room
time for each BMI group, with no significant difference
between groups (ANOVA). (C and D) Hospital length
of stay (LOS). Scatter plot illustrating correlation analysis
between BMI and LOS (A), showing no significant association, and bar graph showing the mean (±SEM) LOS
for each BMI group, with no significant difference
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between groups (ANOVA). (E and F) Total drain volume.
Scatter plot illustrating correlation analysis between BMI
and drain volume (A), showing no significant association, and bar graph showing the mean (±SEM) drain volume for each BMI group, with no significant difference
between groups (ANOVA). (G and H) Drain duration.
Scatter plot illustrating correlation analysis between
BMI and drain duration (A), showing no significant association, and bar graph showing the mean (±SEM) drain
duration for each BMI group, with no significant difference between groups (ANOVA).
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Fig. 5. Functional outcomes of patients with NTOS in
relation to BMI. (A and B) Follow-up change (delta) in
DASH score. Scatter plot illustrating correlation analysis
between BMI and 3-month follow-up change in DASH
score (A), showing no significant association, and bar
graph showing the mean (±SEM) follow-up change in
DASH score for each BMI group, with no significant difference between groups (ANOVA). (C and D) Follow-up

percentage change (delta percent) in DASH score. Scatter
plot illustrating correlation analysis between BMI and
3-month follow-up percentage change in DASH score
(A), showing no significant association, and bar graph
showing the mean (±SEM) follow-up percentage change
in DASH score for each BMI group, with no significant
difference between groups (ANOVA).

and surgical indications for NTOS during the study
period underwent surgical treatment, and there
was no inherent patient-selection bias on the basis
of body weight.
NTOS is a relatively uncommon condition caused
by predisposing variations in anatomy combined
with hypertrophy, injury, and persistent spasm of
the scalene and/or pectoralis minor muscles.15,27
There was an association between BMI and underlying mechanism of injury because the average BMI
for occupational-associated injuries was somewhat
higher than those with recreation-associated
injuries. In addition, those identified as disabled or
unemployed had a higher mean BMI relative to
part-time workers or students, but this variation
was not seen between disabled/unemployed and
those employed full time. In examining other preoperative characteristics of patients with NTOS,
there was a mild association between BMI and
increasing age, but BMI was independent of gender,

side effects, and the presence of an underlying bony
abnormality. Although half of the patients had underlying co-existing medical conditions in addition
to NTOS, most were psychological in nature and
not influenced by body weight. Indeed, the incidence of diabetes in the study population was only
2.3%, allowing us to examine any potential influence of obesity in relative isolation. We therefore
found no evidence to suggest that body weight
had a significant causal relationship to the development or clinical presentation of NTOS.
Patients with NTOS have often had symptoms for
long periods of time before clinical diagnosis, as well
as confounding previous surgical procedures and
chronic use of opioid pain medications. Consistent
with previous studies, 67% of the study cohort
had exhibited symptoms for more than 1 year and
46% for more than 2 years, 18% had undergone
previous surgical procedures involving the ipsilateral neck and/or extremity, and 28% were taking
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Table II. Logistic regression analysis of operative
outcomes for patients with NTOS
Variable

OR

Age
Male gender
BMI group: normal
BMI group:
underweight
BMI group:
overweight
BMI group: obese-I
BMI group: obese-II
BMI group: obese-III
Symptom duration
>2 years
Symptom duration
1e2 years
Symptom duration
7e12 months
Symptom duration
4e6 months
Symptom duration
0e3 months
Diagnosis: anxiety/
depression
Preoperative
opiate use
Work status:
employed
Work status:
unemployed

0.975
0.949e1.000 0.055
0.567
0.292e1.109 0.095
Reference
2.760
0.408e55.810 0.374
1.479

95% CI

P Value

0.760e2.917

0.253

2.080
0.903e5.037
1.913
0.470e9.980
0.669
0.206e2.226
Reference

0.093
0.393
0.503

1.401

0.660e2.973

0.380

1.478

0.668e3.269

0.335

1.539

0.535e4.432

0.424

0.315

0.088e1.128

0.076

1.315

0.684e2.600

0.597

1.208

0.608e2.487

0.419

0.086e0.610

0.004

Reference
0.236

Multivariate logistic regression was used to analyze associations
between various preoperative patient characteristics and
postoperative functional outcome, as measured by a decrease
(improvement) in DASH score at 3-month follow-up.
CI, confidence interval; OR, odds ratio.

opioid medications; however, there were no significant associations found between BMI and the time
interval to clinical presentation, type of interval surgery, or pain medication use. The characteristics of
the patients in this study were therefore generally
comparable with those of others with NTOS, both
in our earlier studies and in those from others, across
the body weight spectrum.29
Given that supraclavicular decompression for
NTOS involves mobilization of the scalene fat pad
and requires careful dissection deep within the anterior neck, we suspected that obesity might have had
an adverse influence on the technical conduct of
surgery or on early postoperative complications,
such as wound infection and persistent lymph
drainage. However, there were no significant differences between the 6 BMI categories in the length of
operation, intraoperative blood loss, amount of fluid
administered, scalene muscle weight, or hospital

length of stay and no differences in the amount of
lymphatic fluid production or drain duration. Hospital readmission rate was also not associated with
BMI, suggesting that those patients at the higher
end of the BMI spectrum did not impose greater
risks for operation or elevated health-care costs in
the setting of treatment for NTOS.
We assessed DASH scores with regard to the
extent of disability at initial presentation and functional outcomes of surgical treatment, a validated
measure of upper extremity disability that has
been used in previous studies on NTOS.17e21,24,29
The high level of pretreatment functional disability
exhibited by patients in this study is reflected by
the mean preoperative DASH score of 59.1 ± 1.2,
similar to that observed in previous studies on
NTOS from our center and others.17e21,24,29 Most
importantly, the changes in DASH scores after surgical treatment were not significantly different between BMI groups, either as evaluated by the
change in absolute DASH scores or by the percentage change from preoperative baseline levels. This
finding suggests that the benefit of supraclavicular
decompression for disabling NTOS is maintained
across the body weight spectrum, with those who
are obese gaining the same benefits from operation
as those at ‘‘normal’’ weight, and at similar levels
of surgical risk. Thus, obesity alone should not be
used to disqualify patients from being considered
for surgical decompression.
One limitation of this study is that the patient
population described here may not be representative of all patients with NTOS but reflects that of a
specialty practice focused on this relatively uncommon condition. The results described here are also
specific to NTOS and do not necessarily translate to
surgical treatment of venous or arterial forms of
TOS. Moreover, the high volume of operative experience in our center may be associated with technical approaches and perioperative care processes
that are not necessarily used in other settings.22,23
It is therefore not clear whether the results of this
study can be generalized to other vascular surgery
or thoracic surgery practice environments where
NTOS may be treated on a far less frequent basis.
A second limitation is that the results of this study
are applicable only to supraclavicular thoracic outlet
decompression, as opposed to other surgical approaches used for NTOS, such as transaxillary first
rib resection. This concern may be particularly relevant given that these 2 operative approaches
involve significant differences in patient positioning, surgical exposure, and the extent of decompression that can be accomplished (e.g., partial
versus complete scalenectomy and feasibility of
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brachial plexus neurolysis). It is therefore not yet
clear if the results described here can also be
extended to any potential influence of body weight
on outcomes of transaxillary first rib resection in the
treatment of NTOS.
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10.

11.

CONCLUSIONS
This study demonstrated no substantive influence of
BMI on preoperative characteristics, intraoperative
findings, technical results, or early postoperative
outcomes for patients undergoing supraclavicular
decompression for NTOS and no indication of an
‘‘obesity paradox’’ for this condition. Supraclavicular decompression for NTOS can therefore be safely
and effectively performed and achieve similar outcomes, across the body weight spectrum. It is not
known if these findings can be extrapolated to other
operative approaches for NTOS.
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